NCT06493994 Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
| NCT ID | NCT06493994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Luebeck |
| Condition | Aortic Valve Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Eligibility Criteria
Inclusion Criteria: * Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement * BMI \<35 kg/m2 * Ability to give informed consent Exclusion Criteria: * History of coronary artery bypass graft and a patent left internal mammary artery (LIMA) * Age ≤18 years * Patients presenting with pregnancy * Patients without informed consent * Expected life expectancy \<2 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06493994 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06493994 currently recruiting?
Yes, NCT06493994 is actively recruiting participants. Contact the research team at ingo.eitel@uksh.de for enrollment information.
Where is the NCT06493994 trial being conducted?
This trial is being conducted at Lübeck, Germany.
Who is sponsoring the NCT06493994 clinical trial?
NCT06493994 is sponsored by University of Luebeck. The trial plans to enroll 100 participants.